Women’s Health Diagnostics Market | High Prevalence of Infectious Diseases in Women

The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period. Factors such as growing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are driving the growth of the market.

Women’s Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021

Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centers are also expected to play a major role in market growth. However, shortage of skilled laboratory technicians and high costs of diagnostics devices, tests, and procedures are hindering the growth of women health diagnostics market. 

Key Questions

⏩ Currently, which are major applications in women’s health diagnostics market and which will be the emerging applications in the near future?
⏩ What are the major end users in market?
⏩ Most of the vendors have opted product launches, agreements, collaborations, & partnerships, and acquisitions as the key growth strategies. Where will it take the industry in the mid to long term in terms of innovation and market growth?
⏩ What are the growth strategies and strengths of market players impacting their market positioning?

Get More Information @https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=128928901